p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells. Ngiwsara L, Ketudat-Cairns JR, Sawangareetrakul P, Charoenwattanasatien R, Champattanachai V, Kuptanon C, Pangkanon S, Tim-Aroon T, Wattanasirichaigoon D, Svasti J*. Ann Hum Genet. 2018 May;82(3):150-157.

01 May 2018
0

p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.

Ngiwsara L, Ketudat-Cairns JR, Sawangareetrakul P, Charoenwattanasatien R, Champattanachai V, Kuptanon C, Pangkanon S, Tim-Aroon T, Wattanasirichaigoon D, Svasti J*.

Ann Hum Genet. 2018 May;82(3):150-157.

Tags

Share this

Related Posts

An engineered cell line lacking OGG1 and MUTYH glycosylases implicates the accumulation of genomic 8-oxoguanine as the basis for paraquat mutagenicity. Tajai, P., Fedeles, B. I., Suriyo, T., Navasumrit, P., Kanitwithayanun, J., Essigmann, J. M., &Satayavivad, J. (2018). Free Radical Biology and Medicine, 116, 64-72.
Ieawsuwan, W.; Pingaew, R.; Kunkaewom, S.; Ploypradith, P.; Ruchirawat, S. Scandium(III) Triflate-Catalyzed Pinacol-Pinacolone Rearrangement and Cyclization of 1,2-Diaryl-1,2-ethanediol: The Versatile Synthesis of 1-Aryl-2,3-dihydro-1H-3-benzazepines. Asian J. Org. Chem. 2019, 8, 1441–1447.

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)